Cargando…
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
OBJECTIVE: To estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care population. RESEARCH DESIGN AND METHODS: A model was developed to estimate first-year medical costs. Model inputs were based on weighted results from three previous studies. Trea...
Autores principales: | Schmier, Jordana K, Covert, David W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874271/ https://www.ncbi.nlm.nih.gov/pubmed/20505836 |
Ejemplares similares
-
First-year treatment costs among new initiators of topical prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2009) -
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2010) -
Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2014) -
Resource Utilization and Costs of Age-Related Macular Degeneration
por: Halpern, Michael T., et al.
Publicado: (2006) -
An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010–2014
por: Schmier, Jordana K, et al.
Publicado: (2016)